High MMP-2 expression was significantly associated with poorer survival in patients with grade II-IV astrocytoma when dichotomized at the median intensity of 117.1 (HR 1.60; 95% CI 1.03–2.48; p = 0.036) (Fig 3C). This evidence concerns the gene MMP2 and astrocytoma (excluding glioblastoma).